---
title: CAR Gene Delivery by T-cell Targeted Lentiviral Vectors is Enhanced by Rapamycin
  Induced Reduction of Antiviral Mechanisms
date: '2023-10-31'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37904721/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231101180626&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Lentiviral vectors (LV) have become the dominant tool for stable gene
  transfer into lymphocytes including chimeric antigen receptor (CAR) gene delivery
  to T cells, a major breakthrough in cancer therapy. Yet, room for improvement remains,
  especially for the latest LV generations delivering genes selectively into T cell
  subtypes, a key requirement for in vivo CAR T cell generation. Toward improving
  gene transfer rates with these vectors, whole transcriptome analyses on human T
  lymphocytes ...
disable_comments: true
---
Lentiviral vectors (LV) have become the dominant tool for stable gene transfer into lymphocytes including chimeric antigen receptor (CAR) gene delivery to T cells, a major breakthrough in cancer therapy. Yet, room for improvement remains, especially for the latest LV generations delivering genes selectively into T cell subtypes, a key requirement for in vivo CAR T cell generation. Toward improving gene transfer rates with these vectors, whole transcriptome analyses on human T lymphocytes ...